Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New shots aim to soothe severe eczema in major pfizer trial

NCT ID NCT05995964

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests two experimental injectable drugs (PF-07275315 and PF-07264660) for adults with moderate to severe atopic dermatitis (eczema) that hasn't improved with skin creams. About 340 participants will receive the drugs or a placebo over up to 13 months to see if the medicines safely reduce itching and rash. The goal is to achieve at least a 75% improvement in eczema severity.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 2

Tests whether the treatment actually works, and watches for side effects, in a larger group.

Participants

About 340 people

The number the study aims to enrol. It can still change while the study runs.

Started

Aug 2023

Expected to finish

Mar 2027

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Must meet the following AD criteria: 1. Participants aged 18 years or older 2. Clinical diagnosis of chronic atopic dermatitis: 1. for at least 6 months prior to Day 1 with diagnosis confirmed by photograph; 2. Either an inadequate response to treatment with standard of care treatments (excluding systemic immunosuppressant treatments) for at least 4 consecutive weeks within 6 to 12 months of the first dose of the study intervention; OR documented reason why topical treatments are considered medically inappropriate; 3. Moderate to severe AD defined as having an affected BSA ≥10%, vIGA ≥3, and EASI ≥16 at both the screening and baseline visits). 4. Bio-experienced cohort-partial or non-responder to anti-inflammatory proteins (also known as biologics), intolerance or AEs to anti-inflammatory proteins or loss of access to anti-inflammatory proteins with ≥12 weeks of treatment within 5 years. Other Inclusion Criteria: 3. BMI of 17.5 to 40 kg/m2; and a total body weight \>45 kg (100 lbs). 4. Willing and able to comply with all scheduled visits, treatment plan, laboratory tests and other study procedures. Exclusion Criteria: \- Medical Conditions: 1. Significant allergic or autoimmune diseases, other than AD and well controlled mild to moderate including but not limited to: SLE or other complement disorders; Type 1 diabetes; IBD; Multiple Sclerosis. 2. History of significant allergic reactions, including anaphylaxis and reactions to protein therapeutics, including hypersensitivity to PF-07275315 or PF-07264660 or to the excipients of the formulated drug products. Participants with significant reactions to single, identified, avoidable allergens (eg, peanut allergy) may be eligible if avoidance of these allergens during the study is feasible. 3. Any of the following acute or chronic infections or infection history: 1. Active infection (including helminth or parasitic) requiring treatment within 2 weeks prior to screening; 2. Infection requiring hospitalization or systemic (parenteral) antimicrobial therapy within 60 days prior to Day 1; 3. Active chronic or acute skin infection requiring treatment with systemic \[(not IV)\] antibiotics, antivirals, antiparasitics, antiprotozoals, or antifungals within 2 weeks prior to Day 1, or superficial skin infections (requiring no more than topical anti-infective treatments) within 1 week prior to Day 1. 4. Any infection judged to be an opportunistic infection or clinically significant by the investigator, within 6 months prior to Day 1; 4. History of or current evidence of inflammatory skin conditions (eg, psoriasis, seborrheic dermatitis, lupus) at the time of Day 1 that could interfere with evaluation of AD or response to treatment. 5. Any medical or psychiatric condition including recent (within the past year) or active suicidal ideation/behavior or laboratory abnormality that may increase the risk of study participation or, in the investigator's judgment, make the participant inappropriate for the study. \- Prior/Concomitant Therapy: 6. Current use of any prohibited concomitant medication(s). 7. Phototherapy narrowband UVB (NB UVB) or broadband phototherapy or regular use (more than 2 visits per week) of a tanning booth/parlor within 4 weeks prior to Day 1. \- Prior/Concurrent Clinical Study Experience: 8. Previous administration with an investigational product (drug or vaccine) within 30 days (or as determined by the local requirement) or 5 half lives preceding the first dose of study intervention used in this study (whichever is longer). 9. HIV infection, or infection with hepatitis B or hepatitis C viruses according to protocol-specific testing algorithm. 10. Evidence of active or latent TB, or inadequately treated infection with Mycobacterium TB. A participant who is currently being treated for active or latent TB infection must be excluded from this study.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Atopic dermatitis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    88 sites in 7 countries. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • AboutSkin Research, LLC

    TERMINATED

    Greenwood Village, Colorado, 80111, United States

  • Affiliated Hospital of Jiangsu University

    NOT_YET_RECRUITING

    Zhenjiang, Jiangsu, 212001, China

  • Allervie Clinical Research

    RECRUITING

    Birmingham, Alabama, 35209, United States

  • Alpesh D. Desai, DO PLLC

    ACTIVE_NOT_RECRUITING

    Houston, Texas, 77008, United States

  • Apex Clinical Research Center

    RECRUITING

    Mayfield Heights, Ohio, 44124, United States

  • Australian Clinical Research Network

    RECRUITING

    Sydney, New South Wales, NSW 2035, Australia

  • BAG Drs. Med. Quist PartG

    RECRUITING

    Mainz, Rhineland-Palatinate, 55128, Germany

  • Banner - University Medicine Dermatology Clinic

    RECRUITING

    Tucson, Arizona, 85718, United States

  • Beijing Friendship Hospital Affiliate of Capital University

    RECRUITING

    Beijing, Beijing Municipality, 100050, China

  • Box Hill Hospital

    RECRUITING

    Box Hill, Victoria, 3128, Australia

  • California Allergy and Asthma Medical Group

    RECRUITING

    Los Angeles, California, 90025, United States

  • Centre de Recherche Saint-Louis inc.

    RECRUITING

    Québec, G1W 4R4, Canada

  • Centrum Medyczne Angelius Provita

    RECRUITING

    Katowice, Silesian Voivodeship, 40-611, Poland

  • Chengdu second people's hospital

    RECRUITING

    Chengdu, Sichuan, 610017, China

  • Clinical Neuroscience Solutions Inc.

    RECRUITING

    Memphis, Tennessee, 38119, United States

  • Clinical Neuroscience Solutions, Inc.

    RECRUITING

    Orlando, Florida, 32801, United States

  • Clinical Partners, LLC

    RECRUITING

    Johnston, Rhode Island, 02919, United States

  • Complete Dermatology

    RECRUITING

    Sugar Land, Texas, 77479, United States

  • DCT-Stone Oak, LLC dba Discovery Clinical Trials

    RECRUITING

    San Antonio, Texas, 78258, United States

  • Dawes Fretzin Clinical Research Group, LLC

    RECRUITING

    Indianapolis, Indiana, 46250, United States

  • DermEdge Research

    RECRUITING

    Mississauga, Ontario, L4Y 4C5, Canada

  • Dermatology Cosmetic Laser Medical Associates of La Jolla, Inc.

    RECRUITING

    San Diego, California, 92121, United States

  • Dermatology Hospital of Jiangxi Province

    RECRUITING

    Nanchang, Jiangxi, 330000, China

  • Dermatology Treatment and Research Center

    RECRUITING

    Dallas, Texas, 75230, United States

  • Dermedic Jacek Zdybski

    RECRUITING

    Ostrowiec Świętokrzyski, Świętokrzyskie Voivodeship, 27-400, Poland

  • Dongguan People's Hospital

    NOT_YET_RECRUITING

    Dongguan, Guangdong, 523109, China

  • Empire Dermatology

    RECRUITING

    East Syracuse, New York, 13057, United States

  • Epic Medical Research - Oklahoma

    RECRUITING

    Chickasha, Oklahoma, 73018, United States

  • Fachklinik Bad Bentheim

    RECRUITING

    Bad Bentheim, Lower Saxony, 48455, Germany

  • First Affiliated Hospital of Kunming Medical University

    RECRUITING

    Kunming, Yunnan, 650032, China

  • Florida International Medical Research

    TERMINATED

    Coral Gables, Florida, 33134, United States

  • Floridian Research Institute Llc

    RECRUITING

    Miami, Florida, 33179, United States

  • ForCare Clinical Research

    RECRUITING

    Tampa, Florida, 33613, United States

  • Fremantle Dermatology

    RECRUITING

    Fremantle, Western Australia, 6160, Australia

  • Fukuwa Clinic

    RECRUITING

    Chuo-ku, Tokyo, 104-0031, Japan

  • GCP Research, Global Clinical professionals

    RECRUITING

    St. Petersburg, Florida, 33705, United States

  • Global Health Research Center, Inc.

    RECRUITING

    Miami Lakes, Florida, 33016, United States

  • Guangdong Province Dermatology Hospital

    RECRUITING

    Guangzhou, Guangdong, 510091, China

  • Hangzhou Third Hospital

    RECRUITING

    Hangzhou, Zhejiang, 310009, China

  • Huashan Hospital, Fudan University

    RECRUITING

    Shanghai, Shanghai Municipality, 200040, China

  • INTERMED Groupe Sante

    RECRUITING

    Chicoutimi, Quebec, G7H 7Y8, Canada

  • Icahn School of Medicine at Mount Sinai

    RECRUITING

    New York, New York, 10029, United States

  • Lima's Excellence in Allergy and Dermatology Research

    RECRUITING

    Hamilton, Ontario, L8L 3C3, Canada

  • MI Skin Innovations

    RECRUITING

    Northville, Michigan, 48167, United States

  • Magdeburger Company for Medical Studies and Services

    RECRUITING

    Magdeburg, Saxony-Anhalt, 39104, Germany

  • Marvel Clinical Research

    RECRUITING

    Huntington Beach, California, 92647, United States

  • Maryland Laser Skin and Vein

    RECRUITING

    Hunt Valley, Maryland, 21030, United States

  • Medical Corporation Heishinkai OPHAC Hospital

    ACTIVE_NOT_RECRUITING

    Osaka, Osaka, 532-0003, Japan

  • Medical Dermatology Specialists

    RECRUITING

    Phoenix, Arizona, 85006, United States

  • Medicor Research Inc

    RECRUITING

    Greater Sudbury, Ontario, P3C 1X3, Canada

  • Michigan Center for Research Company

    RECRUITING

    Clarkston, Michigan, 48346, United States

  • Naoko Dermatology Clinic

    RECRUITING

    Setagaya-ku, Tokyo, 158-0097, Japan

  • National Allergy and Asthma

    RECRUITING

    North Charleston, South Carolina, 29420, United States

  • Niepubliczny Zakład Opieki Zdrowotnej Zespół Poradni Specjalistycznych "Termedica"

    RECRUITING

    Poznan, Greater Poland Voivodeship, 60-681, Poland

  • Nihonbashi Sakura Clinic

    RECRUITING

    Chuo-ku, Tokyo, 103-0025, Japan

  • Nomura Dermatology Clinic

    RECRUITING

    Yokohama, Kanagawa, 221-0825, Japan

  • North Texas Center for Clinical Research

    RECRUITING

    Frisco, Texas, 75034, United States

  • Northridge Clinical Trials

    RECRUITING

    Northridge, California, 91325, United States

  • Onyx Clinical Research

    RECRUITING

    Phoenix, Arizona, 85050, United States

  • Onyx Clinical Research - Peoria

    RECRUITING

    Peoria, Arizona, 85381, United States

  • Osaka Metropolitan University Hospital

    RECRUITING

    Osaka, Osaka, 545-8586, Japan

  • Paddington Testing Co, Inc

    RECRUITING

    Philadelphia, Pennsylvania, 19103, United States

  • Pratia MCM Krakow

    RECRUITING

    Krakow, Lesser Poland Voivodeship, 30-727, Poland

  • Private Practice - Dr. Bobby Buka

    RECRUITING

    New York, New York, 10012, United States

  • Profound Research LLC

    RECRUITING

    Oceanside, California, 92056, United States

  • Renaissance Research and Medical Group

    ACTIVE_NOT_RECRUITING

    Cape Coral, Florida, 33991, United States

  • Revival Research

    RECRUITING

    Doral, Florida, 33122, United States

  • Revival Research Institute LLC

    RECRUITING

    Troy, Michigan, 48084, United States

  • Sadick Research Group

    RECRUITING

    New York, New York, 10075, United States

  • Shanghai First People's Hospital

    RECRUITING

    Shanghai, 201620, China

  • Sinclair Dermatology

    RECRUITING

    East Melbourne, Victoria, 3002, Australia

  • Sir Run Run Shaw Hospital of Zhejiang University School of Medicine

    RECRUITING

    Hangzhou, Zhejiang, 310016, China

  • Skin Specialists, PC dba Schlessinger MD

    RECRUITING

    Omaha, Nebraska, 68144, United States

  • SouthCoast Research Center

    TERMINATED

    Miami, Florida, 33136, United States

  • Southern Indiana Clinical Trials

    RECRUITING

    New Albany, Indiana, 47150, United States

  • Spartanburg Medical Research

    RECRUITING

    Spartanburg, South Carolina, 29303, United States

  • St. Jude Clinical Research

    TERMINATED

    Doral, Florida, 33172, United States

  • Sudbury Skin Clinique

    RECRUITING

    Greater Sudbury, Ontario, P3C 1X8, Canada

  • Sunwise Clinical Research

    TERMINATED

    Walnut Creek, California, 94596, United States

  • Synexus Polska Sp. z o.o. Oddzial w Katowicach

    RECRUITING

    Katowice, 40-040, Poland

  • Synexus Polska Sp. z o.o. Oddzial we Wroclawiu

    RECRUITING

    Wroclaw, Lower Silesian Voivodeship, 50-381, Poland

  • The First Affiliated Hospital Of Fujian Medical University

    RECRUITING

    Fuzhou, Fujian, 350005, China

  • The First Affiliated Hospital of Xi'an Jiaotong University

    RECRUITING

    Xi'an, Shaanxi, 710061, China

  • The First Hospital of Hebei Medical University

    RECRUITING

    Shijiazhuang, Hebei, 050031, China

  • The Second Xiangya Hospital of Central South University

    RECRUITING

    Changsha, Hu'nan, 410011, China

  • The first hospital of jilin university

    RECRUITING

    Changchun, Jilin, 130021, China

  • Tianjin Medical University General Hospital

    NOT_YET_RECRUITING

    Tianjin, Tianjin Municipality, 300052, China

  • Toronto Research Centre

    RECRUITING

    Toronto, Ontario, M3H 5Y8, Canada

  • Union Hospital Tongji Medical College Huazhong University of Science and Technology

    RECRUITING

    Wuhan, Hubei, 430000, China

  • Unity Clinical Research

    RECRUITING

    Oklahoma City, Oklahoma, 73118, United States

  • University Dermatology Trials, INC.

    RECRUITING

    Newport Beach, California, 92660, United States

  • Velocity Clinical Research, Medford

    ACTIVE_NOT_RECRUITING

    Medford, Oregon, 97504, United States

  • Virginia Dermatology and Skin Cancer Center

    TERMINATED

    Norfolk, Virginia, 23502, United States

  • Vital Prospects Clinical Research Institute, PC

    RECRUITING

    Tulsa, Oklahoma, 74136, United States

  • West Dermatology La Jolla

    RECRUITING

    San Diego, California, 92121, United States

  • Wiseman Dermatology Research Inc.

    RECRUITING

    Winnipeg, Manitoba, R3M 3Z4, Canada

  • Zhejiang Provincial People's Hospital

    NOT_YET_RECRUITING

    Hangzhou, Zhejiang, 310014, China

  • Ziaderm Research LLC

    RECRUITING

    North Miami Beach, Florida, 33162, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.